Bourgeon Capital Management LLC Gilead Sciences, Inc. Transaction History

Bourgeon Capital Management LLC

$508 Million
Q2 2024

A detailed history of Bourgeon Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bourgeon Capital Management LLC holds 78,118 shares of GILD stock, worth $6.53 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

78,118

Previous 78,212 0.12%

Holding current value

$6.53 Million

Previous $5.73 Million 6.46%

% of portfolio

1.06%

Previous 1.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$63.15 - $72.88 $5,936 - $6,850	-94 Reduced 0.12%	78,118 $5.36 Million
Q1 2024 Apr 19, 2024	BUY	$71.58 - $87.29 $104,435 - $127,356	1,459 Added 1.9%	78,212 $5.73 Million
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $5.23 Million - $5.93 Million	-71,313 Reduced 48.16%	76,753 $6.22 Million
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $21,516 - $23,474	-291 Reduced 0.2%	148,066 $11.1 Million
Q2 2023 Jul 20, 2023	SELL	$76.01 - $86.7 $56,779 - $64,764	-747 Reduced 0.5%	148,357 $11.4 Million
Q1 2023 Apr 17, 2023	SELL	$77.31 - $88.08 $81,175 - $92,484	-1,050 Reduced 0.7%	149,104 $12.4 Million
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $1.58 Million - $2.27 Million	-25,374 Reduced 14.46%	150,154 $0
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $159,864 - $182,606	2,685 Added 1.55%	175,528 $10.8 Million
Q2 2022 Jul 27, 2022	BUY	$57.72 - $65.01 $156,940 - $176,762	2,719 Added 1.6%	172,843 $10.7 Million
Q1 2022 May 03, 2022	BUY	$57.92 - $72.58 $300,604 - $376,690	5,190 Added 3.15%	170,124 $10.1 Million
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $101,212 - $114,878	1,560 Added 0.95%	164,934 $12 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $1,895 - $2,044	-28 Reduced 0.02%	163,374 $11.4 Million
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $211,799 - $231,420	3,337 Added 2.08%	163,402 $11.3 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $3.43 Million - $3.92 Million	57,222 Added 55.64%	160,065 $10.3 Million
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $2.25 Million - $2.57 Million	-39,774 Reduced 27.89%	102,843 $5.99 Million
Q3 2020 Oct 28, 2020	BUY	$62.1 - $78.08 $3.74 Million - $4.7 Million	60,211 Added 73.07%	142,617 $9.01 Million
Q2 2020 Jul 27, 2020	BUY	$72.34 - $84.0 $1.58 Million - $1.83 Million	21,830 Added 36.04%	82,406 $6.34 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $3.55 Million - $4.55 Million	56,726 Added 1473.4%	60,576 $4.53 Million
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $12,324 - $13,556	-200 Reduced 4.94%	3,850 $250,000
Q3 2019 Nov 04, 2019	BUY	$62.51 - $69.0 $43,757 - $48,300	700 Added 20.9%	4,050 $257,000
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $209,475 - $234,667	3,350 New	3,350 $218,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.

Account

Bourgeon Capital Management LLC Gilead Sciences, Inc. Transaction History